SCHEMBL5320440

SCHEMBL5320440

C=CCOC(=O)CON=C1CN(C(=O)O)Nc2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.40
PKM P14618 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP3A4 P08684 1/20 0.33
RHOA P61586 1/20 0.32
MAPK8 P45983 1/20 0.31
MAPK9 P45984 1/20 0.31
MAPK10 P53779 1/20 0.31
CASP1 P29466 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CYP19A1 P11511 1/20 0.31
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5321199 0.89 CYP3A4 (0.35) NPSR1CYP3A4RHOAALDH1A1TSHR
SCHEMBL5321196 0.89 CYP3A4 (0.35) NPSR1CYP3A4RHOAALDH1A1TSHR
SCHEMBL14224313 0.87 NPSR1 (0.37) NPSR1PKMSMN1; SMN2CYP3A4RHOA
SCHEMBL4865746 0.87 NPSR1 (0.37) NPSR1PKMSMN1; SMN2CYP3A4RHOA
SCHEMBL14196724 0.86 NPSR1 (0.41) NPSR1PKMSMN1; SMN2CYP3A4RHOA
SCHEMBL5320723 0.83 MAPK8 (0.40) MAPK8MAPK9MAPK10ALDH1A1MEN1
SCHEMBL5320718 0.83 MAPK8 (0.40) MAPK8MAPK9MAPK10ALDH1A1MEN1
SCHEMBL14196720 0.76 MAPK1 (0.38) NPSR1CYP3A4RHOACYP19A1ALDH1A1
SCHEMBL4860414 0.76 MAPK1 (0.38) NPSR1CYP3A4RHOACYP19A1ALDH1A1
SCHEMBL5322672 0.69 CASP1 (0.37) NPSR1PKMSMN1; SMN2CYP3A4CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537117-B1 BENZOTRIAZABICYCLIC DERIVATIVES AND USE THEREOF AS BETA-LACTAMASE INHIBITORS AND ANTI-BACTERIAL AGENTS AVENTIS PHARMA SA (FR) 2007-01-17 EP disclosed